Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Accentia Biopharmaceuticals, Inc.
Accentia Biopharmaceuticals to Present at Rodman & Renshaw 10th Annual Healthcare Conference; Company Also Reports On NASDAQ Compliance Plan
November 14th, 2008
Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI) announced that it will present at the Rodman & Renshaw 10th Annual Healthcare Conference on November 11, 2008 at 10:20 a.m. (EDT) at the New York Palace Hotel in New York City. The Company's presentation will focus on its BiovaxID(R) personalized anti-cancer vaccine. Accentia's majority-owned subsidiary, Biovest International, Inc. (OTCBB:BVTI), recently reported encouraging BiovaxID Phase 3 clinical trial results for the treatment of non-Hodgkin's lymphoma, and the Company is now progressing with plans to seek approvals in the U.S., Europe and other international countries. If qualified investors are interested in meeting...
Source: Health Business Week (2008-11-14)
|
